Skip to Content

Nuveen International Eq Idx Premier TRIPX

Medalist Rating as of | See Nuveen Investment Hub
  • NAV / 1-Day Return 23.36  /  +1.13 %
  • Total Assets 25.2 Bil
  • Adj. Expense Ratio
    0.200%
  • Expense Ratio 0.200%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield 2.83%
  • Turnover 8%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis TRIPX

Will TRIPX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Nuveen International Eq Idx Premier's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TRIPX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 15.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.53 644.2 Mil
Healthcare

ASML Holding NV

2.19 557.0 Mil
Technology

Nestle SA

1.62 412.9 Mil
Consumer Defensive

AstraZeneca PLC

1.36 347.2 Mil
Healthcare

Shell PLC

1.33 337.2 Mil
Energy

Toyota Motor Corp

1.32 336.6 Mil
Consumer Cyclical

Lvmh Moet Hennessy Louis Vuitton SE

1.26 321.3 Mil
Consumer Cyclical

Msci Eafe Jun24 Ifus 20240621

1.19 301.8 Mil

Novartis AG Registered Shares

1.17 297.2 Mil
Healthcare

SAP SE

1.09 277.4 Mil
Technology